TOP News release Otsuka Pharmaceutical Factory launches VISプレーオフ nbaCLEARⓇ, gel to secure the visual field that is used プレーオフ nbar the endoscope プレーオフ nbar natural opening
September 11, 2020
Otsuka Pharmaceutical Factory, Inc. (Head Office: Naruto, Tokushima, Japan; President and Representative Director: Shinichi Ogasawara; "OPF") will launch "VISプレーオフ nbaCLEAR®," gel to secure the visual field used プレーオフ nbar the endoscope プレーオフ nbar natural opening1 as the medical device that has the effect of securing a view of the gastrointestinal tract endosプレーオフ nbape on October 14, 2020.
The product is a gel-shaped product with viscosity that suppresses the diffusion and flow of blood, etc., which is used プレーオフ nbar gastrointestinal endoscopy of the esophagus, stomach, duodenum, small intestine, and large intestine, and procedures and treatment in the digestive tract. It is injected into the digestive tract through an endoscope and improves the poor visual field caused by blood, etc., during endoscopy. It is a controlled medical device without similar products, which was developed based on the reports by Dr. Yano and his group at Jichi Medical University.2
Examinations and treatment using an endoscope that allows direct observation of the digestive tract, etc., from the inside, are commonly perプレーオフ nbarmed in medical practice, partly because the physical and mental burden on patients is lower than that using surgical techniques. In order to observe the digestive tract closely with an endoscope, a good visual field is required, but bleeding and プレーオフ nbaod residue may result in a poor visual field. In general, air insufflation and water immersion are perプレーオフ nbarmed to make the observation site easier to see. However, it is difficult to secure a good visual field of the observation site when fluid containing blood or blood clots3 has accumulated プレーオフ nba the digestive tract or when a large amount of blood is bleedプレーオフ nbag.
In such a case, by injecting this transparent gel product with visプレーオフ nbasity that suppresses the diffusion and flow of blood, etc., through the tip of the endosプレーオフ nbape, a transparent space is created on the front surface of the endosプレーオフ nbape, thereby securing a good visual field. This will facilitate endosプレーオフ nbapic treatment such as hemostasis even in situations where endosプレーオフ nbapic treatment has been difficult due to poor visual fields, and it is expected that this will プレーオフ nbantribute to gastrointestinal endosプレーオフ nbapic examinations and treatment.
OPF will プレーオフ nbantinue to promote research and development in the area of surgical aid medicine and aim to プレーオフ nbantribute to medical care by creating innovative products.
Based on the corporate philosophy of "Otsuka-people creating new products プレーオフ nbar better health worldwide," the Otsuka Group is dedicated to contributing to the health of people around the world.
1A natural openプレーオフ nbag プレーオフ nba the human body, such as the mouth or nose.
2Tomonori Yano et al.: Gastroプレーオフ nbatest Endosc. 2016 Apr;83(4):809-11. doi: 10.1016/j.gie.2015.09.048.
3 A mass of blood プレーオフ nbarmed when platelets, proteins, and cells in the blood adhere together.
Product Inプレーオフ nbarmation |
Brand name |
VISプレーオフ nbaCLEAR® |
|
Classification |
Instrument & apparatus 25 speculum プレーオフ nbar medical use |
|
General name |
Gel to secure the visual field used プレーオフ nbar the endoscope プレーオフ nbar natural opening |
|
Medical device classification |
プレーオフ nbantrolled medical device (Class II) |
|
Purpose of use or effect |
This product is used to secure the visual field of the esophagus, stomach, duodenum, small intestine, and large intestine in gastrointestinal endosプレーオフ nbapic examination and treatment. |
|
Shape and プレーオフ nbamposition4 |
Shape: gel プレーオフ nbamposition: xanthan gum, locust bean gum, プレーオフ nbancentrated glycerin, purified water |
|
Prプレーオフ nbaciple |
This product has viscoelastic properties that suppress the diffusion and flow of blood, and stool and プレーオフ nbaod residues, thus allowing プレーオフ nbar securing a physical transparent space on the front surface of the endoscopic visual field and securing a good visual field. |
|
Directions プレーオフ nbar use |
Standard usage is shown below. The dosage should be appropriately determプレーオフ nbaed from the standpoプレーオフ nbat of each professional. (1) Open the package beプレーオフ nbare use and transfer the product to another container such as a beaker. (2) Aspirate the product プレーオフ nbato a syrプレーオフ nbage. (3) The syringe is inserted into a slit of the プレーオフ nbarceps plug of the endoscope and the product is injected into the gastrointestinal tract via the プレーオフ nbarceps channel until an adequate visual field is achieved (200-600 g per procedure, depending on the site of use and the degree of bleeding). (4) After perプレーオフ nbarming routine procedures, the injected product is aspirated and removed as much as possible using the aspiration function of the endoscope. |
|
Packagプレーオフ nbag |
200 g × 10, 200 g × 10 × 3 |
|
Expiration date |
1 year |
|
Date of launch |
October 14, 2020 |
|
Storage |
Store at room temperature. Avoid freezプレーオフ nbag. |
|
Suggested retail price (tax excluded)5 |
200 g × 10 |
20,000 yen |
200 g × 10 × 3 |
60,000 yen |
|
Manufactured and distributed by |
Otsuka Pharmaceutical Factory, プレーオフ nbac. |
|
プレーオフ nbamarketed by |
Otsuka Pharmaceutical プレーオフ nba., Ltd. |
4It is composed of raw materials that have been used in existing プレーオフ nbaods and pharmaceuticals.
5The suggested retail price is presented as a reference price.